The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement

Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy

(2016) E Smretschnig et al.   EYE

Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration

(2016) Yingyan Ma et al.   OPTOMETRY AND VISION SCIENCE

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Is it time to confine Snellen charts to the annals of history?

(2015) Jan E. Lovie-Kitchin   OPHTHALMIC AND PHYSIOLOGICAL OPTICS

Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration

(2015) Marc C. Peden et al.   OPHTHALMOLOGY

Outcome of conventional treatment for adult amblyopia

(2013) Fumiko Kishimoto et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Visual acuity testing. From the laboratory to the clinic

(2013) Ian L. Bailey et al.   VISION RESEARCH

Blindness and Visual Impairment in an Urban West African Population: The Tema Eye Survey

(2012) Donald L. Budenz et al.   OPHTHALMOLOGY

Visual acuity changes in cone and cone-rod dystrophies

(2011) Elena Prokofyeva et al.   OPHTHALMIC AND PHYSIOLOGICAL OPTICS

The effect of treatment zone diameter in hyperopic orthokeratology

(2009) Paul Gifford et al.   OPHTHALMIC AND PHYSIOLOGICAL OPTICS

Is BCVA an invention of ophthalmology?

(2008) H Barry Collin   Clinical and Experimental Optometry

Complex juxtapapillary capillary hemangioma: A case report

(2008) Sherrol A. Reynolds et al.   OPTOMETRY